Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-22

Clinical Trial Update: PVB vs Ketamine/Lidocaine in Rib Fracture Patients [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing paravertebral block (PVB) to ketamine/lidocaine for rib fracture pain has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)
  • Lidocaine (Lidocaine)

Snippet

Sponsor: George Washington University | Conditions: Rib Fractures, Rib Trauma | EARLY_Phase 1 | Status: TERMINATED